Name | N-[3-[(4-fluorophenyl)sulfonylamino]-4-methoxyphenyl]-4-phenylbenzamide |
---|---|
Synonyms |
MLS000417014
N-(3-(4-fluorophenylsulfonamido)-4-methoxyphenyl)-[1,1'-biphenyl]-4-carboxamide |
Description | SN-001 is a STING inhibitor with an IC50 of 3.82 μM[1]. |
---|---|
Related Catalog | |
Target |
IC50: 3.82 μM (STING)[1] |
In Vitro | SN-001 targets the cyclic dinucleotide binding pocket of human STING[1]. SN-001 (5-20 μM; 6 h) significantly impairs the induction of Ifnb mRNA, in a dose-dependent manner in L929 cells[1]. SN-001 (10 μM; 3 h) inhibits cytosolic DNA-triggered STING signaling[1]. Western Blot Analysis[1] Cell Line: L929 cells Concentration: 10 μM Incubation Time: 3 h Result: Decreased cytosolic DNA-induced phosphorylation of STING, TBK1, IRF3, IκBα, and p65, as well as nuclear translocation of IRF3 and p65. |
Molecular Formula | C26H21FN2O4S |
---|---|
Molecular Weight | 476.522 |
Exact Mass | 476.121 |